← Back to Search

Smoking Cessation Intervention for Cancer Patients

N/A
Waitlist Available
Led By Jamie Ostroff, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older
Diagnosed with cancer or have a mass suspicious of cancer that is NOT distant metastatic cancer at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to help cancer patients quit smoking before and after surgery, compared to the current standard of care.

Who is the study for?
This trial is for adults over 18 with cancer or a mass that might be cancer, who are not in the distant metastatic stage and are candidates for surgery in no less than 7 days. Participants must be mentally sound, able to use a phone and PDA, willing to consent, and smoke more than 8 cigarettes daily or frequently use other tobacco.
What is being tested?
The study compares two smoking cessation methods before surgery: one uses scheduled reduced smoking plus nicotine patches; the other employs hospital counseling alongside nicotine patches. The goal is to determine which method better helps patients quit tobacco use pre- and post-surgery.
What are the potential side effects?
Potential side effects from nicotine replacement therapy can include skin irritation from patches, sleep problems (insomnia), headache, dizziness, racing heartbeat (tachycardia), muscle pain and stiffness, nausea/vomiting, diarrhea/constipation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have cancer or a mass that may be cancer, but it has not spread far from where it started.
Select...
I do not have any severe mental health issues or cognitive impairments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Hospital Counseling + Nicotine Replacement Therapy + Pre-surgical Schedule Reduced Smoking (HC+NRT+PS/SRS)
Group II: 1Active Control1 Intervention
Hospital Counseling + Nicotine Replacement Therapy (HC+NRT)

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,969 Previous Clinical Trials
597,047 Total Patients Enrolled
M.D. Anderson Cancer CenterOTHER
3,066 Previous Clinical Trials
1,802,041 Total Patients Enrolled
Jamie Ostroff, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
16 Previous Clinical Trials
6,796 Total Patients Enrolled

Media Library

Hospital Counseling + Nicotine Replacement + Presurgical Scheduled Reduced Smoking 2023 Treatment Timeline for Medical Study. Trial Name: NCT00575718 — N/A
~7 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top